News

National Institutes of Health awards Elucid Bioimaging 2nd year of SBIR grant “vascuCAP: Non-invasive Computer-Aided Phenotyping of Vasculopathy.

June 6, 2016
National Institutes of Health awards Elucid Bioimaging SBIR grant to establish vascuCAP as fit for use in both personalized medicine as well as drug development. August 2015 Elucid Bioimaging is pleased to be in receipt of a Small Business Innovation Research (SBIR) grant award notice from the National Heart, Lung, and Blood Institute of the… View Article

Dr. Michael Rosol joins staff as Senior Director of Business Development

May 1, 2016
Michael Rosol, Ph.D., Senior Director of Business Development   Dr. Rosol is a biomedical imaging professional with extensive commercial experience, notably in his prior position as Head of the Translational Imaging Group at Novartis Pharmaceuticals, which provides him with deep insights into the needs of industry for the development, validation, and implementation of imaging biomarkers… View Article

Issued patent: Classification of Biological Tissue by Multi-Mode Data Registration, Segmentation, and Characterization. US Patent 9,235,887

January 12, 2016

National Institutes of Health awards Elucid Bioimaging SBIR grant to establish vascuCAP as fit for use in both personalized medicine as well as drug development.,

August 1, 2015
National Institutes of Health awards Elucid Bioimaging SBIR grant to establish vascuCAP as fit for use in both personalized medicine as well as drug development. August 2015 Elucid Bioimaging is pleased to be in receipt of a Small Business Innovation Research (SBIR) grant award notice from the National Heart, Lung, and Blood Institute of the… View Article

Elucid Bioimaging featured in National Institutes of Health and the National Science Foundation Innovation Zone at 2015 BIO International Convention in Philadelphia

June 1, 2015